ZYDUS LIFESCIENCES
Back to Income Statement
|
ZYDUS LIFESCIENCES Last 5 Year Revenue History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Sales | ₹17,237 Cr | ₹15,110 Cr | ₹14,404 Cr | ₹14,253 Cr | ₹13,166 Cr |
What is the latest Revenue of ZYDUS LIFESCIENCES ?
Year | Revenue |
---|---|
Mar2023 | ₹17,237 Cr |
Mar2022 | ₹15,110 Cr |
Mar2021 | ₹14,404 Cr |
Mar2020 | ₹14,253 Cr |
Mar2019 | ₹13,166 Cr |
How is Revenue of ZYDUS LIFESCIENCES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2023 | ₹17,237 Cr | 14.08 | |
Mar2022 | ₹15,110 Cr | 4.90 | |
Mar2021 | ₹14,404 Cr | 1.06 | |
Mar2020 | ₹14,253 Cr | 8.26 | |
Mar2019 | ₹13,166 Cr | - |
Compare Revenue of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹101,198.6 Cr | 1.8% | 2.2% | 88.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,071.0 Cr | 0.2% | -6.1% | 55.7% | Stock Analytics | |
CIPLA | ₹111,808.0 Cr | -2.5% | -5.1% | 48.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,300.0 Cr | -0.9% | 5% | 19.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,035.0 Cr | -3.7% | -1.4% | 26% | Stock Analytics | |
MANKIND PHARMA | ₹87,328.3 Cr | -6.6% | -6.6% | NA | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | 1.8% |
2.2% |
88.6% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses